Tonghua Golden-Horse Pharmaceutical Industry Co Ltd banner
T

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766

Watchlist Manager
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
Watchlist
Price: 22.93 CNY 1.87% Market Closed
Market Cap: ¥22.2B

Balance Sheet

Balance Sheet Decomposition
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

Balance Sheet
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
31
9
19
5
27
6
10
13
39
18
15
7
19
53
79
211
363
319
278
415
203
235
167
274
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
202
234
167
274
Cash Equivalents
31
9
19
5
27
6
10
13
39
18
15
7
19
53
79
210
363
318
278
414
1
1
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
262
263
18
7
0
0
0
1
1
Total Receivables
1 062
741
661
478
414
151
174
179
181
205
189
185
157
114
242
420
648
860
955
573
459
506
556
542
Accounts Receivables
402
134
130
99
100
114
128
143
142
144
132
138
90
43
122
252
419
637
740
435
351
424
497
500
Other Receivables
660
607
531
379
314
37
46
36
38
61
57
47
67
70
119
168
229
223
215
139
108
82
59
42
Inventory
119
87
50
16
43
284
278
280
279
276
282
290
289
299
375
433
415
440
409
435
385
381
369
382
Other Current Assets
39
58
16
21
45
36
37
35
28
30
24
36
47
5
25
41
38
63
38
106
106
115
18
11
Total Current Assets
1 251
895
745
521
529
477
497
506
527
529
511
517
512
471
737
1 366
1 727
1 699
1 687
1 529
1 152
1 238
1 111
1 210
PP&E Net
179
181
253
147
157
136
130
128
130
123
117
119
246
474
745
967
1 039
1 053
1 038
1 018
1 092
1 063
1 032
1 017
PP&E Gross
179
181
253
147
157
136
130
128
130
123
117
119
246
474
745
967
1 039
1 053
1 038
1 018
1 092
1 063
1 032
1 017
Accumulated Depreciation
71
83
95
85
97
87
99
111
123
132
143
149
151
160
65
105
148
202
250
296
336
390
443
491
Intangible Assets
39
38
34
21
22
183
177
172
166
161
164
159
189
184
262
402
388
416
402
390
386
377
374
374
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 764
2 002
2 002
2 058
2
2
2
2
2
2
Long-Term Investments
1
7
2
0
0
0
1
1
41
84
85
95
155
155
566
479
475
727
1 516
1 990
1 989
1 989
1 986
1 848
Other Long-Term Assets
0
410
407
403
399
4
4
4
5
6
4
6
5
3
84
88
95
44
52
48
20
15
15
33
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 764
2 002
2 002
2 058
2
2
2
2
2
2
Total Assets
1 469
N/A
1 531
+4%
1 441
-6%
1 091
-24%
1 107
+1%
800
-28%
809
+1%
812
+0%
869
+7%
903
+4%
880
-3%
895
+2%
1 107
+24%
1 286
+16%
4 156
+223%
5 304
+28%
5 727
+8%
5 997
+5%
4 698
-22%
4 977
+6%
4 641
-7%
4 685
+1%
4 519
-4%
4 484
-1%
Liabilities
Accounts Payable
20
31
39
27
39
35
23
23
27
24
24
28
38
43
79
97
93
175
173
188
149
216
183
182
Accrued Liabilities
29
52
71
66
46
151
168
147
173
194
0
1
2
2
18
39
59
65
64
33
42
54
38
35
Short-Term Debt
925
904
890
849
0
0
0
0
0
0
0
0
34
0
10
150
435
155
130
125
42
31
138
263
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
75
92
104
250
163
1 623
202
11
1 603
Other Current Liabilities
20
53
85
112
100
83
69
75
72
76
236
234
391
351
1 535
234
202
270
288
255
172
169
202
73
Total Current Liabilities
993
1 040
1 085
1 054
185
269
260
245
273
294
260
263
465
396
1 677
595
881
770
905
764
2 028
672
572
2 157
Long-Term Debt
1
0
60
0
0
0
0
0
0
0
0
0
0
200
145
206
216
359
989
1 814
188
1 568
1 560
3
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
8
14
11
9
7
5
4
3
Minority Interest
3
2
2
0
0
0
0
0
0
0
0
0
0
0
0
39
38
36
35
34
33
32
0
0
Other Liabilities
0
0
0
0
876
13
13
13
13
13
13
13
27
30
87
330
203
107
127
85
79
72
65
66
Total Liabilities
997
N/A
1 042
+5%
1 147
+10%
1 054
-8%
1 062
+1%
282
-73%
273
-3%
258
-6%
285
+11%
307
+7%
273
-11%
275
+1%
492
+79%
626
+27%
1 909
+205%
1 181
-38%
1 346
+14%
1 285
-5%
2 067
+61%
2 706
+31%
2 334
-14%
2 348
+1%
2 202
-6%
2 228
+1%
Equity
Common Stock
449
449
449
449
449
449
449
449
449
449
449
449
449
449
726
967
967
967
967
967
966
966
966
966
Retained Earnings
366
350
544
790
781
807
789
771
742
730
718
714
710
705
698
486
228
103
1 978
2 338
2 302
2 272
2 228
2 172
Additional Paid In Capital
389
389
389
416
416
876
876
876
876
876
876
885
876
916
2 219
3 642
3 642
3 642
3 642
3 642
3 642
3 642
3 579
3 579
Unrealized Security Profit/Loss
0
0
0
39
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119
Total Equity
472
N/A
489
+3%
294
-40%
37
-88%
45
+24%
518
+1 044%
537
+4%
554
+3%
584
+5%
596
+2%
607
+2%
620
+2%
615
-1%
660
+7%
2 246
+241%
4 123
+84%
4 381
+6%
4 712
+8%
2 631
-44%
2 271
-14%
2 307
+2%
2 337
+1%
2 318
-1%
2 255
-3%
Total Liabilities & Equity
1 469
N/A
1 531
+4%
1 441
-6%
1 091
-24%
1 107
+1%
800
-28%
809
+1%
812
+0%
869
+7%
903
+4%
880
-3%
895
+2%
1 107
+24%
1 286
+16%
4 156
+223%
5 304
+28%
5 727
+8%
5 997
+5%
4 698
-22%
4 977
+6%
4 641
-7%
4 685
+1%
4 519
-4%
4 484
-1%
Shares Outstanding
Common Shares Outstanding
449
449
449
449
449
449
449
449
449
449
449
449
449
449
726
967
967
967
967
967
966
966
966
966
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett